Collecting data for MSTX
. This company stock is not elastic to its hype. The average elasticity to hype of competition is -0.66. Mast Therapeutics Inc is projected to decline in value after the next headline with price expected to drop to 0.49. The average volatility of media hype impact on the company stock price is about 0.0%. The price decrease on the next news is expected to be -0.2% where as daily expected return is now at -0.24%. The volatility of related hype on Mast is about 109.45% with expected price after next announcement by competition of -0.17. About
of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.31. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mast Therapeutics Inc recorded
. This company had not issued any dividends in recent years. The firm had
on April 26, 2010. Given the investment horizon of 30 days, the next projected press release will be uncertain.